États-Unis · Plateformes & données · MarketBeat

Vor Biopharma Inc. (VOR) - What Are Investment Firms Thinking About This Stock?

Publié par MarketBeat · États-Unis il y a 1 h

Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten ratings firms that are presently covering the stock,…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Vor Biopharma Inc. (VOR) - What Are Investment Firms Thinking About This Stock?

À lire aussi

France business activity deteriorates in October, missing consensus

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Not Bitcoin. Not Ethereum. This Once-Popular Cryptocurrency Could Be the Biggest Winner of 2027.

Why is Crest Nicholson stock falling today?

Stocktwits AI Roundup: Meta’s Capex, Lam’s Supply Warning Hit Tech Stocks As Netflix Disappoints

Rakuten Medical Presents Long-Term Follow-up Results of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for R/M HNSCC at ESMO 2026

Vor Biopharma Inc. (VOR) - What Are Investment Firms Thinking About This Stock?

Partager

À lire aussi

France business activity deteriorates in October, missing consensus

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Not Bitcoin. Not Ethereum. This Once-Popular Cryptocurrency Could Be the Biggest Winner of 2027.

Why is Crest Nicholson stock falling today?

Stocktwits AI Roundup: Meta’s Capex, Lam’s Supply Warning Hit Tech Stocks As Netflix Disappoints

Rakuten Medical Presents Long-Term Follow-up Results of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for R/M HNSCC at ESMO 2026